The Insight Partners published latest research report on “Frozen Tissues Samples Market Size Report, Share, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application and End User”, the global market is projected to reach USD 105,045.91
The Insight Partners published latest research report on "Frozen Tissues Samples Market Size Report, Share, Trends, Growth & Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application and End User”, the global market is projected to reach USD 105,045.91 thousand by 2028 from USD 44,399.07 thousand in 2021. The market is estimated to grow at a CAGR of 13.1% during 2021–2028.
Request Sample PDF Brochure: https://www.theinsightpartners.com/sample/TIPRE00016644
Growth Strategies by the Key Players Operating in the Frozen Tissues Samples Market:
Dec 2021 - AMS Biotechnology (Europe) Ltd. opened a new office in Alkmaar, Netherlands. By maintaining local stock – AMSBIO Europe BV enables EU customers to order and receive the company's market-leading life science products with unimpeded efficiency and lower costs in the post-Brexit market.
Nov 2021 - Audubon partnered with MicroVentures, an equity crowdfunding platform, to carry out a campaign to help finance the company's global expansion. The company raised US$ 348,456 from 763 investors.
Oct 2021 - REPROCELL and Hoth Therapeutics, Inc. extended their partnership agreement to assess the effect of the HT-003 therapeutic platform in inflammatory bowel disease (IBD). In the partnership, fresh explants of ulcerative colitis and Crohn’s disease tissues will be used to investigate the therapeutic potential of Hoth's HT-003 drugs. Also, all testing will be performed at REPROCELL's Centre for Predictive Drug Discovery.
May 2019 - VIROCLINICS-DDL announced the signing of renewal for the collaboration agreement with REPROCELL. REPROCELL will provide sample processing services to VIROCLINICS-DDL to support several clinical research projects. As per the collaboration, REPROCELL provided sample processing services in Japan to VIROCLINICS-DDL and supported COVID-19 clinical research projects from May 2021 until July 2021. REPROCELL joined VIROCLINICS-DDL’s extensive global processing laboratory network to assist with several clinical research studies.
Frozen tissues samples are tissues from the human body that are used for research for disease diagnosis, treatment, cancers, and morphological analysis. Frozen tissue samples can be of three types – frozen normal tissues, frozen diseased tissues, and frozen tumor tissues. Frozen tissue samples are preferred in analyses such as next-generation sequencing, western blotting for post-translational protein modifications, mass spectrometry, and quantitative real-time polymerase chain reaction. The biopsy material is dipped in liquid nitrogen and stored in an ultra-cold freezer. Frozen tissue samples are the gold standard for DNA and RNA sequencing, especially when the strands must be longer than 50 pairs. In immunohistochemistry, frozen tissue samples are also helpful as the proteins are still preserved in their native state. The market players in the frozen tissues samples market collect and create biorepositories of these frozen tissues samples and provide them to clients in the form of frozen tissue samples, frozen tissue arrays, and frozen tissue panels, as per client requirements. These biorepositories have increased significantly, with government and research organizations also creating their own biobanks for the collection and storage of tissue samples. Various market players also provide custom services to collect fresh tissues for specific diseases as per client requirements.
Directly Purchase Premium Copy of Frozen Tissues Samples Market Growth Report (2021-2028) at: https://www.theinsightpartners.com/buy/TIPRE00016644
Global Frozen Tissues Samples Market Share Report, Segmentations, Regional & Country Scope:
Report Coverage |
Details |
Market Size Value in |
USD 44,399.07 thousand in 2021 |
Market Size Value by |
USD 105,045.91 thousand by 2028 |
Growth rate |
CAGR of 13.1% from 2021 to 2028 |
Forecast Period |
2021-2028 |
Base Year |
2021 |
No. of Pages |
167 |
No. of Tables |
86 |
No. of Charts & Figures |
73 |
Historical data available |
Yes |
Segments covered |
Product Type, Application, and End User |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
US, UK, Canada, Germany, France, Italy, Australia, Russia, China, Japan, South Korea, Saudi Arabia, Brazil, Argentina |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Companies Covered |
Audubon Bioscience Co, REPROCELL Inc., Bay Biosciences LLC, US Biolab Corporation, Inc, AMS Biotechnology (Europe) Ltd., Geneticist, Inc, ZenBio, Inc, OriGene Technologies, Inc., BioChain Institute Inc, ProteoGenex, Inc. |
Key Research Capabilities |
Global Market Assessment, Business Development Strategies, Competitive Landscape, Opportunity Analysis, Regional and Country Level Market Analysis, Market Entry Strategies, Market Dynamics, Risk and Return Assessments, Pricing Analysis, Market Size and Forecasting, Company Profiling, Value Chain Analysis, Expansion Strategies, SWOT Analysis, New Product Development |
Browse key market insights spread across 167 pages with 86 list of tables & 73 list of figures from the report, "Frozen Tissues Samples Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Frozen Normal Tissue Samples, Frozen Tumor Tissue Samples, and Frozen Diseased Tissue Samples), Application (Disease Diagnosis & Treatment, Cancer & Other Diseases Research, and Morphological Analysis), and End User (Academic & Research Institutes, Hospitals & Clinics, Diagnostic Centers, and Others)" in detail along with the table of contents: https://www.theinsightpartners.com/reports/frozen-tissues-samples-market
Biopsies are small samples of tissue extracted from a mass or tumor studied under a microscope to determine the cause of the bulge or tumor. Biopsies are generally used to diagnose cancer cells, infections, and other disorders. The frozen section is a type of biopsy treatment that was created to make a quick identification of a mass during surgery. Cryosection is the technical term for the procedure, and the cryostat is the instrumentation utilized in it. This procedure is mainly performed during oncology-related surgeries. Frozen tissue samples are helpful in the identification of lesions or tumors as they allow a surgeon to see if a sample has malignant or benign components and if the tumor has metastasized. The surgeon can then decide whether there is a compelling reason to continue the surgery.
Furthermore, frozen tissue samples are occasionally used to confirm the presence of a lesion or skip a lesion in surgically suspect tissue areas. Determining the organ of origin using frozen tissue samples is important when dealing with tissues such as parathyroid glands that are too small and difficult to recognize. Moreover, frozen tissue samples are utilized to determine whether the tumor has spread to the lymph nodes and nerves. It is sometimes also used to check for distant organ metastasis. Frozen tissue samples are preferred in analyses such as mass spectrometry, next-generation sequencing, western blotting for post-translational protein modifications, and quantitative real-time polymerase chain reaction. In addition, when the strands are longer than 50 pairs, frozen tissue samples are the gold standard for DNA and RNA sequencing. Frozen tissue samples are also beneficial in immunohistochemistry as the proteins are still in their native state. Furthermore, several research studies are conducted using frozen tissue samples in various therapeutic areas such as oncology, inflammation, neurological diseases/central nervous system (CNS), normal tissues, and others. For instance, Rheumatoid Arthritis (RA), a chronic autoimmune disorder causing joint inflammation and damage, is one of the most studied indications in recent years. Frozen tissue samples have been used widely in medical research on cancer and other disorders to examine cell morphology, disease state, intra and intercellular communication, and sections of biopsied tissue. As most biological materials are fragile and perishable, special precautions are ensured for frozen tissue samples and preserved. Therefore, the rising application of frozen tissue samples in various research and therapeutic areas is driving the frozen tissues samples market.
The growing medical infrastructure, coupled with technological advancements, is driving the frozen tissue samples market. Moreover, the rising investment by major market players in the frozen tissue samples market is anticipated to boost market growth. However, the risk associated with preserving and maintaining frozen tissue samples is expected to hamper the market's growth.
Go through further research published by The Insight Partners: (Purchase with 10% Instant Discount):
Bio-Banking Human Samples Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Sample Preparation Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Sample Collection Tube Market Forecast to 2028 - COVID-19 Impact and Global Analysis
Automated Sample Storage Systems Market Forecast to 2028 - Covid-19 Impact and Global Analysis
Current Sampling Resistance Market Forecast to 2028 - COVID-19 Impact and Global Analysis
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials.
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Sameer Joshi
E-mail: sales@theinsightpartners.com
Phone: +1-646-491-9876
Press Release: https://www.theinsightpartners.com/pr/frozen-tissues-samples-market